Beatriz Fernández-Fernández Selected Research

Beatriz Fernández-Fernández Research Topics

Disease

5	Inflammation (Inflammations) 01/2023 - 11/2013
4	Chronic Renal Insufficiency 05/2024 - 06/2014
3	Diabetic Nephropathies (Diabetic Nephropathy) 10/2022 - 01/2020
3	Proteinuria 09/2021 - 01/2020
2	Fibrosis (Cirrhosis) 01/2023 - 01/2020
2	Albuminuria 10/2022 - 09/2016
2	Necrosis 01/2021 - 01/2016
2	Glomerulonephritis 01/2020 - 01/2016
1	Arteriosclerosis 05/2024
1	Prediabetic State (Prediabetes) 05/2024
1	Sclerosis 05/2024
1	Obesity 03/2024
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2024
1	Heart Failure 03/2024
1	Dementia (Dementias) 03/2024
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Hyperkalemia 01/2023
1	Acute Kidney Injury (Acute Renal Failure) 12/2022
1	Hypoglycemia (Reactive Hypoglycemia) 03/2020
1	Weight Loss (Weight Reduction) 03/2020
1	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2020
1	Hemolytic-Uremic Syndrome 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 03/2017
1	Diabetes Mellitus 10/2016
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2016
1	Hypercholesterolemia 09/2016
1	Familial Hypophosphatemia (Phosphate Diabetes) 09/2016
1	Leg Ulcer 01/2016
1	Iron Overload 06/2014
1	Hyperphosphatemia 06/2014

Drug/Important Bio-Agent (IBA)

3	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 10/2022
3	IronIBA 03/2017 - 06/2014
2	AlbuminsIBA 05/2024 - 10/2022
2	dapagliflozinIBA 03/2024 - 10/2022
2	Mineralocorticoid Receptor AntagonistsIBA 03/2024 - 01/2023
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2024 - 03/2020
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021 - 01/2020
2	Phosphates (Orthophosphate)IBA 10/2016 - 06/2014
1	HDL LipoproteinsIBA 05/2024
1	CreatinineIBA 05/2024
1	Triglycerides (Triacylglycerol)IBA 05/2024
1	semaglutideIBA 03/2024
1	8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA 03/2024
1	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2024
1	omega-Chloroacetophenone (Mace)IBA 03/2024
1	Sodium-Glucose Transporter 2 InhibitorsIBA 03/2024
1	finerenoneIBA 01/2023
1	PotassiumIBA 01/2023
1	Anticonvulsants (Antiepileptic Drugs)IBA 12/2022
1	Opioid Analgesics (Opioids)IBA 12/2022
1	DiureticsIBA 12/2022
1	Vasopressins (Vasopressin)IBA 12/2022
1	Prescription DrugsIBA 12/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022
1	CanagliflozinIBA 10/2022
1	empagliflozinIBA 10/2022
1	Proteins (Proteins, Gene)FDA Link 10/2022
1	Cytokine TWEAKIBA 10/2022
1	SodiumIBA 10/2022
1	Messenger RNA (mRNA)IBA 10/2022
1	protein phosphatase 6IBA 01/2021
1	goralatideIBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021
1	Type 2 Angiotensin ReceptorIBA 01/2021
1	AnkyrinsIBA 01/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021
1	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2021
1	Threonine (L-Threonine)FDA Link 01/2021
1	Serine (L-Serine)FDA Link 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Endothelin Receptors (Endothelin Receptor)IBA 01/2020
1	CateninsIBA 03/2017
1	Insulin (Novolin)FDA Link 03/2017
1	Metformin (Glucophage)FDA LinkGeneric 03/2017
1	Parathyroid Hormone (Parathormone)IBA 10/2016
1	Fibroblast Growth Factor-23IBA 10/2016
1	Calcifediol (Calcidiol)FDA Link 10/2016
1	Proprotein Convertase 9IBA 09/2016
1	Vitamin E FDA LinkGeneric 09/2016
1	LipidsIBA 09/2016
1	CholesterolIBA 09/2016
1	ReninIBA 09/2016
1	Polymethyl Methacrylate (Sol)IBA 01/2016
1	sucroferric oxyhydroxideIBA 06/2014
1	HematinicsIBA 06/2014
1	ferric citrateIBA 06/2014
1	sulforaphaneIBA 11/2013

Therapy/Procedure

2	Therapeutics 01/2020 - 09/2016
1	Nephrectomy 09/2021
1	Glycemic Control 03/2020
1	Microspheres (Microsphere) 01/2016
1	Subcutaneous Injections 01/2016